Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform

06/08/21 New Multi Reflecting Time-of-Flight (MRT) mass spectrometry platform from Waters delivers highest quality resolution at fast speedsi. Exceptional clarity of molecular structures and location in tissues for spatial-omics applications with enhanced Desorption Electrospray Ionization (DESI) and new Matrix-Assisted Laser Desorption Ionization (MALDI) imaging sources. Waters SELECT SERIES MRT platform to serve as basis for... Read more

Thermo Fisher Scientific Launches Ion AmpliSeq SARS-CoV-2 Insight Research Assay for SARS-CoV-2 Surveillance

Thermo Fisher Scientific Launches Ion AmpliSeq SARS-CoV-2 Insight Research Assay for SARS-CoV-2 Surveillance Panel enables early identification of new and known variants from a variety of sample types CARLSBAD, Calif., June 7, 2021 /PRNewswire/ — Thermo Fisher Scientific today introduced the Ion AmpliSeq SARS-CoV-2 Insight Research Assay to improve SARS-CoV-2 surveillance. The assay is designed to enable... Read more

Thermo Fisher Scientific Launches Novel Flow Cytometer with Imaging Capability

Invitrogen Attune CytPix Flow Cytometer* enables researchers and cell therapy developers to collect fluorescent data and high resolution images CARLSBAD, Calif., June 7, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Invitrogen Attune CytPix Flow Cytometer, an imaging-enhanced flow cytometer that combines acoustic focusing flow... Read more

Thermo Fisher Scientific and Newomics Develop New Approaches to LC-MS Analysis of Native Protein Complexes

Thermo Fisher Scientific and Newomics Develop New Approaches to LC-MS Analysis of Native Protein Complexes SAN JOSE, Calif., June 7, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Newomics a commercial-stage biotechnology company, are collaborating to develop a novel native liquid chromatography-mass spectrometry (LC−MS) platform to support various LC−MS applications. This... Read more

Bruker Launches CE-IVD Quantitative Coronavirus Mid-Plex PCR Assay with Mutation Detection for Routine Variant Differentiation

FluoroType® SARS-CoV-2 varID Q is a novel LiquidArray® mid-plex PCR panel Detection of selected SARS-CoV-2 mutations enables differentiation of major viral variants, or strains, without the costs and delays of selective NGS for variant epidemiology Quantification of viral load provides indication of infectivity and of stage of COVID infection Validated with nasopharyngeal swabs and oropharyngeal... Read more

Agilent Announces New SureSelect Human All Exon V8

Design provides comprehensive content and flexible exome options SANTA CLARA, Calif., June 02, 2021  Agilent Technologies Inc. (NYSE: A) today announced the release of SureSelect Human All Exon V8 – a new exome design that provides comprehensive content and up-to-date coverage of protein-coding regions from RefSeq, CCDS, and GENCODE. It also covers the TERT promoter and hard-to-capture... Read more

Bruker Launches timsTOF SCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth

Unique timsTOF SCP revolutionizes quantitative single cell biology research with unbiased, deep single-cell 4D-Proteomics™ to complement scRNA-seq; breakthrough paper by Mann et al. identifies and quantifies >1,400 proteins in single cells Next-generation timsTOF Pro 2 with unprecedented depth and throughput for unbiased 4D-Proteomics; supports liquid biopsy multiomic biomarker research, integrating genomics with proteomics and epiproteomics;... Read more

Bruker Launches timsTOF trueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth

Unique timsTOF trueSCP revolutionizes quantitative single cell biology research with unbiased, deep single-cell 4D-Proteomics™ to complement scRNA-seq; breakthrough paper by Mann et al. identifies and quantifies >1,400 proteins in single cells Next-generation timsTOF Pro 2 with unprecedented depth and throughput for unbiased 4D-Proteomics; supports liquid biopsy multiomic biomarker research, integrating genomics with proteomics and epiproteomics;... Read more

European Commission approves Venclyxto-based combinations for adults with newly diagnosed acute myeloid leukaemia who are ineligible for intensive chemotherapy

With hypomethylating agents significantly improved complete response rates in certain adults with newly diagnosed acute myeloid leukaemia In the VIALE-A study, Venclyxto plus azacitidine significantly improved overall survival in patients ineligible for intensive chemotherapy, a patient population who typically have a five-year overall survival rate of less than 10%1 Study data reinforces the potential of... Read more